RGI offers state-of-the-art technologies, a comprehensive range of Preimplantation Genetic Testing (PGT) and embryology services.
PGT-A
for Aneuploidy
PGT-M
for Monogenic/Single Gene Defects
PGT-SR
for Structural Rearrangements
PGT-HLA
for Human Leukocyte Antigen
PGT-A
PGT-A helps identify embryos with the correct number of chromosomes before embryo transfer. PGT-A can also help lower the risk of failed implantation, miscarriage, and certain chromosome-related conditions.
PGT-M
PGT-M helps identify embryos that are not expected to be affected by a specific inherited genetic condition before pregnancy begins. This gives patients and providers valuable information when making treatment decisions and helps to reduce the risk of passing on a known genetic disorder. RGI is a leader in customized PGT-M testing and offers specialized tests for many rare and complex conditions that may not be available at other laboratories.
PGT-SR
PGT-SR helps patients who carry a chromosome rearrangement identify embryos with a balanced chromosome makeup before embryo transfer. This can help lower the risk of failed implantation, miscarriage, and certain chromosome-related conditions, giving patients and providers more confidence when making treatment decisions.
PGT-HLA
PGT-HLA may be an option for families who have a child with a genetic disorder that needs a bone marrow or cord blood transplant. The test helps identify embryos that are not expected to be affected by the condition and that may be a match for their sibling. If a match is found, stem cells from the baby's umbilical cord blood may be used to help treat the affected child.